A detailed history of Godsey & Gibb Associates transactions in Amgen Inc stock. As of the latest transaction made, Godsey & Gibb Associates holds 62,677 shares of AMGN stock, worth $16.5 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares
62,677
Previous 63,980 2.04%
Holding current value
$16.5 Million
Previous $20 Million 1.03%
% of portfolio
1.93%
Previous 2.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$309.38 - $337.38 $403,122 - $439,606
-1,303 Reduced 2.04%
62,677 $20.2 Million
Q2 2024

Jul 23, 2024

BUY
$262.75 - $319.31 $20,231 - $24,586
77 Added 0.12%
63,980 $20 Million
Q1 2024

Apr 23, 2024

BUY
$268.87 - $324.56 $90,071 - $108,727
335 Added 0.53%
63,903 $18.2 Million
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $393,522 - $443,939
1,539 Added 2.48%
63,568 $18.3 Million
Q3 2023

Oct 25, 2023

BUY
$218.65 - $271.46 $552,091 - $685,436
2,525 Added 4.24%
62,029 $16.7 Million
Q2 2023

Jul 25, 2023

BUY
$214.27 - $253.37 $12.5 Million - $14.8 Million
58,490 Added 5768.24%
59,504 $13.2 Million
Q1 2023

Apr 18, 2023

SELL
$225.79 - $275.2 $67,737 - $82,560
-300 Reduced 22.83%
1,014 $245,000
Q4 2022

Jan 18, 2023

BUY
$229.03 - $291.01 $300,945 - $382,387
1,314 New
1,314 $0
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $201,664 - $230,786
-1,014 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $5,306 - $6,217
-25 Reduced 2.41%
1,014 $216,000
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $29,197 - $32,392
-125 Reduced 10.74%
1,039 $253,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $258,303 - $301,010
1,164 New
1,164 $290,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $319,994 - $372,901
-1,442 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $4,760 - $5,668
22 Added 1.55%
1,442 $332,000
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $13,140 - $14,613
56 Added 4.11%
1,420 $361,000
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $5,340 - $6,553
-27 Reduced 1.94%
1,364 $322,000
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $32,256 - $42,780
177 Added 14.58%
1,391 $282,000
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $42,383 - $54,476
-224 Reduced 15.58%
1,214 $293,000
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $18,107 - $21,696
-104 Reduced 6.74%
1,438 $278,000
Q2 2019

Aug 07, 2019

BUY
$166.7 - $195.41 $37,340 - $43,771
224 Added 17.0%
1,542 $284,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $238,386 - $268,713
1,318 New
1,318 $250,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.